Secreted phospholipase A2 inhibitors are also potent blockers of binding to the M-type receptor

Biochemistry

Volumn 45, Issue 44, 2006, Pages 13203-13218

  Boilard, Eric ^a   Rouault, Morgane ^a   Surrel, Fanny ^a   Le Calvez, Catherine ^a   Bezzine, Sofiane ^a   Singer, Alan ^b   Gelb, Michael H ^b   Lambeau, Gérard ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; CATALYST ACTIVITY; CONCENTRATION (PROCESS); ENZYME INHIBITION; HYDROLYSIS; PHOSPHOLIPIDS;

COMPETITIVE INHIBITORS; M-TYPE RECEPTORS; PATHOPHYSIOLOGICAL FUNCTIONS; PHOSPHOLIPASES;

ENZYMES;

INDOLE DERIVATIVE; INDOXAM; M TYPE RECEPTOR; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPID; PYRAZOLE; RECEPTOR; SNAKE VENOM; UNCLASSIFIED DRUG; CARBAMIC ACID DERIVATIVE; ENZYME INHIBITOR; INDOLIZINE DERIVATIVE; MEMBRANE PROTEIN; PHOSPHOLIPASE A;

ARTICLE; BINDING COMPETITION; CONCENTRATION RESPONSE; CROSS LINKING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; IC 50; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; WESTERN BLOTTING; ANIMAL; BINDING SITE; CATALYSIS; CHEMICAL STRUCTURE; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; MOUSE; RABBIT;

MAMMALIA;

ANIMALS; BINDING SITES; CARBAMATES; CATALYSIS; ENZYME INHIBITORS; INDOLIZINES; MEMBRANE PROTEINS; MICE; MODELS, MOLECULAR; PHOSPHOLIPASES A; RABBITS; SNAKE VENOMS;

EID: 33750734264     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi061376d     Document Type: Article

References (88)

1. Berg, O. G., Gelb, M. H., Tsai, M. D., and Jain, M. K. (2001) Interfacial enzymology: The secreted phospholipase A2 paradigm, Chem. Rev. 101, 2613-2654 .
2. Valentin, E., and Lambeau, G. (2000) Increasing molecular diversity of secreted phospholipases A2 and their receptors and binding proteins, Biochim. Biophys. Acta 1488, 59-70.
3. Rouault, M., Bollinger, J. G., Lazdunski, M., Gelb, M. H., and Lambeau, G. (2003) Novel mammalian group XII seereted phospholipase A2 lacking enzymatic activity, Biochemistry 42, 11494-11503.
4. Diaz, B. L., and Arm, J. P. (2003) Phospholipase A2, Prostaglandins, Leukotrienes Essent. Fatty Acids 69, 87-97.
5. Laye, J. P., and Gill, J. H. (2003) Phospholipase A2 expression in tumours: A target for therapeutic intervention? Drug Discovery Today 8, 710-716.
6. Scott, K. F., Graham, G. G., and Bryant, K. J. (2003) Secreted phospholipase A2 enzymes as therapeutic targets, Expert Opin. Ther. Targets 7, 427-440.
7. Murakami, M., and Kudo, I. (2004) Secretory phospholipase A2, Biol. Pharm. Bull. 27, 1158-1164.
8. Webb, N. R. (2005) Secretory phospholipase A2 enzymes in atherogenesis, Curr. Opin. Lipidol. 16, 341-344.
9. Piris-Gimenez, A., Paya, M., Lambeau, G., Chignard, M., Mock, M., Touqui, L., and Goossens, P. L. (2005) In vivo protective role of human group IIa phospholipase A2 against experimental anthrax, J. Immunol. 175, 6786-6791.
10. Dong, Q., Patel, M., Scott, K. F., Graham, G. G., Russell, P. J., and Sved, P. (2006) Oncogenic action of phospholipase A2 in prostate cancer, Cancer Lett. 240, 9-16.
11. Triggiani, M., Granata, F., Giannattasio, G., and Marone, G. (2005) Secretory phospholipases A2 in inflammatory and allergic diseases: Not just enzymes, J. Allergy Clin. Immunol. 116, 1000-1006.
12. Bezzine, S., Koduri, R. S. Valentin, E., Murakami, M., Kudo, I., Ghomashchi, F., Sadilek, M., Lambeau, G., and Gelb, M. H. (2000) Exogenously added human group X secreted phospholipase A2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells, J. Biol. Chem. 275, 3179-3191.
13. Kim, Y. J., Kim, K. P., Rhee, H. J., Das, S., Rafter, J. D., Oh, Y. S., and Cho, W. (2002) Internalized group V secretory phospholipase A2 acts on the perinuclcar membranes, J. Biol. Chem. 277, 9358-9365.
14. Hanasaki, K., and Arita, H. (2003) Biological functions of group X secretory PLA2, Adv. Exp. Med. Biol. 525, 93-96.
15. Murakami, M. (2004) Hot topics in phospholipase A2 field, Biol. Pharm. Bull. 27, 1179-1182.
16. 2-α. J. Biol Chem. 279, 25024-25038.
17. Ni, Z., Okeley, N. M., Smart, B. P., and Gelb, M. H. (2006) Intracellular Actions of Group IIA Secreted Phospholipase A2 and Group IVA Cytosolic Phospholipase A2 Contribute to Arachidonic Acid Release and Prostaglandin Production in Rat Gastric Mucosal Cells and Transtected Human Embryonic Kidney Cells, J. Biol. Chem. 281, 16245-16255.
18. Satake, Y., Diaz, B. L., Balestrieri, B., Lam, B. K., Kanaoka, Y., Grusby, M. J., and Arm, J. P. (2004) Role of group V phospholipase A2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted aene disruption, J. Biol. Chem. 279, 16488-16494.
19. Saiga, A., Uozumi, N., Ono, T., Seno, K., Ishimoto, Y., Arita, H., Shimizu, T., and Hanasaki, K. (2005) Group X secretory phospholipase A2 can induce arachidonic acid release and eicosanoid production without activation of cytosolic phospholipase A2 α, Prostaglandins Other Lipid Mediators 75, 79-89.
20. Balsinde, J., and Balboa, M. A. (2005) Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells, Cell. Signalling 17, 1052-1062.
21. Mandal, A. K., Zhang, Z., Chou, J. Y., and Mukherjee, A. B. (2001) Pancreatic phospholipase A2 via its receptor regulates expression of key enzymes of phospholipid and sphingolipid metabolism, FASEB J. 15, 1834-1836.
22. Hanasaki, K., and Arita, H. (2002) Phospholipase A2 receptor: A regulator of biological functions of secretory phospholipase A2, Prostaglandins Other Lipid Mediators 68-69, 71-82.
23. 2, J. Biol. Chem. 280, 24987-24998.
24. Vadas, P., Wasi, S., Movat, H. Z., and Hay, J. B. (1981) Extracellular phospholipase A2 mediates inflammatory hyperaemia, Nature 293, 583-585.
25. Vadas, P., Browning, J., Edelson, J., and Pruzanski, W. (1993) Extracellular phospholipase A2 expression and inflammation: The relationship with associated disease states, J. Lipid Mediators 8, 1-30.
26. 2, Biochim. Biophys. Acta 1488, 149-158.
27. 2 in inflammatory diseases and trauma, Biochim. Biophys. Acta 1488, 83-90.
28. Pruzanski, W., and Vadas, P. (1991) Phospholipase A2: A mediator between proximal and distal effectors of inflammation, Immunol. Today 12, 143-146.
29. Wery, J. P., Schevitz, R. W., Clawson, D. K., Bobbitt, E. R., Dow, E. R., Gamboa, G., Goodson, T., Hermann, R. B., Jr., Kramer, R. M., McClure, D. B., Michelich, E. D., Putnam, J. E., Sharp, J. D., Stark, D. H., Teater, C., Warrick, M. W., and Jones, N. D. (1991) Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolution, Nature 352, 79-82.
30. Springer, D. M. (2001) An update on inhibitors of human 14 kDa Type II s-PLA2 in development, Curr Pharm. Des. 7, 181-198.
31. Reid, R. C. (2005) Inhibitors of secretory phospholipase A2 group IIA, Curr. Med. Chem. 12, 3011-3026.
32. Schevitz, R. W., Bach, N. J., Carlson, D. G., Chiraadze, N. Y., Clawson, D. K., Dillard, R. D., Draheim, S. E., Hartley, L. W., Jones, N. D., Mihelich, E. D., et al. (1995) Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2, Nat. Struct. Biol. 2, 458-465.
33. Smart, B. P., Oslund, R. C., Walsh, L. A., and Gelb, M. H. (2006) The first potent inhibitor of mammalian group X secreted phospholipase A2: Elucidation of sites for enhanced binding, J. Med. Chem. 49, 2858-2860.
34. Arbibe, L., Koumanov, K., Vial, D., Rougeot, C., Faure, G., Havet, N., Longacre, S., Vargaftig, B. B., Bereziat, G., Voelker, D. R., Wolf, C., and Touqui, L. (1998) Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction, J. Clin. Invest. 102, 1152-1160.
35. Furue, S., Mikawa, K., Nishina, K., Shiga, M., Ueno, M., Tomita, Y., Kuwabara, K., Teshirogi, I., Ono, T., Hori, Y., Matsukawa, A., Yoshinaga, M., and Obara, H. (2001) Therapeutic time-window of a group IIA phospholipase A2 inhibitor in rabbit acute lung injury: Correlation with lung surfactant protection, Crit. Care Med. 29, 719-727.
36. Woodruff, T. M., Arumugam, T. V., Shiels. I. A., Newman, M. L., Ross, P. A., Reid, R. C., Fairlie, D. P., and Taylor, S. M. (2005) A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis, Int. Immunopharmacol. 5, 883-892.
37. Svensson, C. I., Lucas, K. K., Hua, X. Y., Powell, H. C., Dennis, E. A., and Yaksh, T. L. (2005) Spinal phospholipase A2 in inflammatory hyperalgesia: Role of the small, secretory phospholipase A2, Neuroscience 133, 543-553.
38. Shoscyov, D., Bihi, H., Offer, S., Sehwob, O., Krimsky, M., Kleiman, M., and Yedgar, S. (2005) Treatment of ovalbumin-induced experimental allergic bronchitis in rats by inhaled inhibitor of secretory phospholipase A2, Thorax 60, 747-753.
39. Gregory, L. S., Kelly, W. L., Reid, R. C., Fairlie, D. P., and Forwood, M. R. (2006) Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats, Bone 39, 134-142.
40. Yokota, Y., Hanasaki, K., Ono, T., Nakazato, H., Kobayashi. T., and Arita, H. (1999) Suppression of murine endoloxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms, Biochim. Biophys. Acta 1438, 213-222.
41. Abraham, E., Nauru, C., Bandi, V., Gervich, D., Lowry, S. F., Wunderink, R., Schein, R. M., Macias, W., Skerjanec, S., Dmitrienko, A., Farid, N., Forgue, S. T., and Jiang, F. (2003) Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure, Crit. Care Med. 31, 718-728.
42. Zeiher, B. G., Steingrub, J., Laterre, P. F., Dmitrienko, A., Fukiishi, Y., and Abraham, E. (2005) LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis, Crit. Care Med. 33, 1741-1748.
43. Bowton, D. L., Dmitrienko, A. A., Israel, E., Zeiher, B. G., and Sides, G. D. (2005) Impact of a soluble phospholipase A2 inhibitor on inhaled allerucn challenge in subjects with asthma, J. Asthma 42, 65-71.
44. Bradley, J. D., Dmitrienko, A. A., Kivitz, A. J., Gluck, O. S., Weaver, A. L., Wiesenhuller, C., Myers, S. L., and Sides, G. D. (2005) A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis, J. Rheumatol. 32, 417-423.
45. Suzuki, N., Ishizaki, J., Yokota, Y., Higashino, K., Ono, T., Ikeda, M. Fujii, N., Kawamoto, K., and Hanasaki, K. (2000) Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipases A2, J. Biol. Chem. 275, 5785-5793.
46. Singer, A. G., Ghomashchi, F., Le Calvez, C., Bollinger, J., Bezzine, S., Rouault, M., Sadilek, M., Nguyen, E., Lazdunski, M., Lambeau, G., and Gelbm M. M. (2002) Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2, J. Biol. Chem. 277, 48535-48549.
47. 2 in rodents during inflammation, Biochim. Biophys. Acta 1635, 37-47.
48. 2 by indole analogues: A structure-guided study, Bioorg. Med. Chem. Lett. 12, 1737-1749.
49. Rizzo, M. T., Nguyen, E., Aldo-Benson, M., and Lambeau, G. (2000) Secreted phospholipase A2 induces vascular endothelial cell migration, Blood 96, 3809-3815.
50. Boilard, E., Bourgoin, S. G., Bernatehez, C., and Surette, M. E. (2003) Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2, Blood 102, 2901-2909.
51. Jo, E. J., Lee, H. Y., Lee, Y. N., Kim, J. L. Kang, H. K., Park, D. W., Hack, S. H., Kwak, J. Y., and Bae, Y. S. (2004) Group IB secretory phospholipase A2 stimulates CXC chemokine ligand 8 production via ERK and NF-κB in human neutrophils, J. Immunol. 173, 6433-6439.
52. Lee, C., Park, D. W., Lee, J., Lee, T. L. Kim, Y. J., Lee, Y. S., and Back, S. H. (2006) Secretory phospholipase A2 induces apoptosis through TNF-α and cytochrome c-mediated caspase cascade in murine macrophage RAW 264.7 cells, Eur. J. Pharmacol. 536, 47-53.
53. Tada, K., Murakami, M., Kambe, T., and Kudo, I. (1998) Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal must cells is facilitated by interaction with fibroblasts und mediated by a mechanism independent of their enzymatic functions, J. Imnmnol. 161, 5008-5015.
54. 2-dependent induction of cyclooxygenase-2 in macrophages, J. Biol. Chem. 274, 25967-25970.
55. Bidgood, M. J., Jamal, O. S., Cunningham, A. M., Brooks, P. M., and Scott, K. F. (2000) Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cylokins-mediated prostaglandin production in human rheumatoid synoviocytes, J. Immunol. 165, 2790-2797.
56. 2, FEBS Lett. 531, 7-11.
57. Beck, S., Lambeau, G., Scholz-Pedretti, K., Gelb M. H., Janssen, M. J., Edwards, S. H., Wilton, D. C., Pfeilschifter, J., and Kaszkin, M. (2003) Potentiation of TNFα-induced sPLA2-IIA expression in mesangial cells hy an autocrine loop involving secreted phospholipase A2 and PPARα activation, J. Biol. Chem. 278, 29799-29812.
58. Choi, Y. A., Lim, H. K., Kim, J. R., Lee, C. H., Kim, Y. J., Kang, S. S., and Baek, S. H. (2004) Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol-3 kinase and Akt pathway, J. Biol. Chem. 279, 36579-36585.
59. Granata, F., Petraroli, A., Boilard, E., Bezzine, S., Bollinger, J., Del Vecchio, L., Gelb, M. H., Lambeau, G., Marone, G., and Triggiani, M. (2005) Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor, J. Immunol. 174, 464-474.
60. 2 in human lung macrophages, Eur. J. Immunol. (in press).
61. Laine, V. J., Grass, D. S., and Nevalainen, T. J. (1999) Protection by group II phospholipase A2 against Staphylococcus aureus, J. Immunol. 162. 7402-7408.
62. Femling, J. K., Nauseef, W. M., and Weiss, J. P. (2005) Synergy between Extracellular Group IIA Phospholipase A2 and Phagocyte NADPH Oxidase in Digestion of Phospholipids of Staphylococcus aureus Ingested by Human Neutrophils, J. Immunol. 175, 4653-4661.
63. Guillaume, C., Calzada, C., Lagarde, M., Schrevel, J., and Deregnaucourt, C. (2006) Interplay between lipoproteins and bee venom phospholipase A2 in relation to their anti-plasmodium toxicity, J. Lipid. Res. (in press).
64. Fenard, D., Lambeau, G., Valentin, E., Lefebvre, J. C., Luzdunski, M., and Doglio, A. (1999) Secreted phospholipases A2, a new class of HIV inhibitors that block virus entry into host cells, J. Clin. Invest. 104, 611-618.
65. Mitsuishi, M., Masuda, S., Kudo, I., and Murakami, M. (2006) Group V and X secretory phospholipase A2 prevents adenoviral infection in mammalian cells, Biochem. J. 393, 97-106.
66. Koprivnjak, T., Peschel, A., Gelb, M. H., Liang, N. S., and Weiss, J. P. (2002) Role of charge properties of bacterial envelope in bactericidal action of human group IIA phospholipase A2 against Staphylococcus aureus, J. Biol. Chem. 277, 47636-47644.
67. Jaulmes, A., Janvierm B., Andreanim M., and Raymondjean, M. (2005) Autocrine and Paracrine Transcriptional Regulation of Type IIA Secretory Phospholipase A2 Gene in Vascular Smooth Muscle Cells, Arterioscler. Thromb. Vasc. Biol. 25, 1161-1167.
68. Murakami, M., Nakatani, Y., Kuwata, H., and Kudo, I. (2000) Cellular components that functionally interact with signaling phospholipase A2s, Biochim. Biophys. Acta 1488, 159-166.
69. Boilard, E., Bourgoin, S. G., Bernatchez, C., Poubelle, P. E., and Surette, M. E. (2003) Interaction of low molecular weight group IIA phospholipuse A2 with apoptotic human T cells: Role of hcparan sulfate proteoglycans, FASEB J. 17, 1008-1080.
70. Lambeau, G., and Lazdunski, M. (1999) Receptors for a growing family of secreted phospholipases A2, Trends Pharmacol. Sci. 20, 162-170.
71. Hanasaki, K., Yokota, Y., Ishizaki, J., Itoh, T., and Arita, H. (1997) Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice, J. Biol. Chem. 272, 32792-32797.
72. Cupillard, L., Mulherkur, R., Gomez, N., Kadam, S., Valentin, E., Lazdunski, M., and Lambeau, G. (1999) Both group IB und group IIA secreted phospholipases A2 are natural ligands of the mouse M-type receptor, J. Biol. Chem. 274, 7043-7051.
73. 2 receptor, FEBS Lett. 478, 187-191.
74. Rouault, M., Rash, L. D., Escoubas, P., Boilard, E., Bollinger, J., Lomonte, B., Maurin, T., Guillaume, C., Canaan, S., Deregnaucourt, C., Schrevel, J., Doglio, A., Gutierrez, J. M., Lazdunski, M., Gelb, M. H., and Lambeau, G. (2006) Neurotoxicity and Other Pharmacological Activities of the Snake Venom Phospholipase A2 OS2: The N-Terminal Region Is More Important Than Enzymatic Activity, Biochemistry 45, 5800-5816.
75. Lena, G., Lallemaud, E., Gruner, A. C., Boeglin, J., Roussel, S., Schaffner, A. P., Aubry, A., Frunetich, J. F., Muzier, D., Landau, I., Briand, J. P., Didierjean, C., Renia, L., and Guichard, G. (2006) 1,3,5-Trtazepan-2,6- diones as Structurally Diverse and Conformationally Constrained Dipeptide Mimetics: Identification of Malaria Liver Stage Inhibitors from a Small Pilot Library, Chem.-Eur. J. (in press).
76. Lambeau, G., Ancian, P., Barhanin, J., and Lazdunski, M. (1994) Cloning and expression of a membrane receptor for secretory phospholipases A2, J. Biol. Chem. 269, 1575-1578.
77. Lambeau, G., Ancian, P., Nicolas, J. P., Beiboer, S., Moinier, D., Verheij, H., and Lazdunski, M. (1995) Structural elements of secretory phospholipases A2 involved in the binding to M-type receptors, J. Biol. Chem. 270, 5534-5540.
78. Kitadokoro, K., Hagishita, S., Sato, T., Ohtani, M., and Miki, K. (1998) Crystal structure of human secretory phospholipase A2-IIA complex with the potent indolizine inhibitor 120-1032, J. Biochem. 123, 619-623.
79. Murakami, M., Kambe, T., Shimbara, S., Yamamoto, S., Kuwata, H., and Kudo, I. (1999) Functional association of type IIA secretory phospholipase A2 with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway, J. Biol. Chem. 274, 29927-29936.
80. Muller, P., Lena, G., Boilard, E., Bezzine, S., Lambeau, G., Guichard, G., and Rognan, D. (2006) In silico-guided target identification of a scaffold focused library: 1,3,5-Triazepan-2,6-diones as novel phospholipase A2 inhibitors, J. Med. Chem. (in press).
81. Tzung, S. P., Kim, K. M., Basanez, G., Giedt, C. D., Simon, J., Zimmerberg, J., Zhang, K. Y., and Hockenbery, D. M. (2001) Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3, Nat. Cell Biol. 3, 183-191.
82. Vassilev, L. T., Vu, B. T., Graves, B., Curvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., Fotouhim N., and Liu, E. A. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2, Science 303, 844-848.
83. Pan, Y. H., Epstein, T. M., Jain, M. K., and Bahnson, B. J. (2001) Five coplanar union binding sites on one face of phospholipase A2: Relationship to interface binding, Biochemistry 40, 609-617.
84. Chabot, S., Koumanov, K., Lambeau, G., Gelb, M. H., Chignard, M., Whitsett, J. A., and Touqui, L. (2003) Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2, J. Immunol. 171, 995-1000.
85. Yamazakt, Y., Matsunaga, Y., Nakano, Y., and Monta, T. (2005) Identification of vascular endothelial growth factor receptor-binding protein in the venom of eastern cottonmouth. A new role of snake venom myotoxic Lys49-phospholipase A2, J. Biol. Chem. 280, 29989-29992.
86. Buitrago-Rey, R., Olarte, J., and Gomez-Marin, J. E. (2002) Evaluation of two inhibitors of invasion: LY311727 [3-(3-acelamide-1-benzyl-2-ethyl-indolyl- 5-oxy)propane phosphonic acid] and AEBSF [4-(2-aminoethyl)-benzenesulphonyl fluoride] in acute murine toxoplasmosis, J. Antimicrob. Chemother. 49, 871-874.
87. Jain, M. K., Yuan, W., and Gelb, M. H. (1989) Competitive inhibition of phospholipase A2 in vesicles, Biochemistry 28, 4135-4139.
88. McMartin, C., and Bohacek, R. S. (1997) QXP: Powerful, rapid computer algorithms for structure-based drug design, J. Comput.-Aided Mol. Des. 11, 333-344.